UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
t-plasminogen activator (779) 779
science & technology (632) 632
life sciences & biomedicine (470) 470
stroke (362) 362
ischemia (336) 336
humans (326) 326
tissue plasminogen activator (292) 292
thrombolysis (265) 265
male (246) 246
hemorrhage (216) 216
patients (208) 208
female (195) 195
intravenous administration (184) 184
neurosciences & neurology (173) 173
animals (165) 165
science & technology - other topics (155) 155
multidisciplinary sciences (153) 153
medicine (150) 150
middle aged (144) 144
aged (142) 142
fibrin (135) 135
proteins (132) 132
science (130) 130
neurosciences (125) 125
mortality (124) 124
research article (120) 120
thrombosis (113) 113
tissue plasminogen activator - therapeutic use (107) 107
clinical neurology (106) 106
fibrinolysis (101) 101
stroke - drug therapy (101) 101
analysis (97) 97
studies (96) 96
plasminogen activator inhibitors (91) 91
risk factors (90) 90
brain (89) 89
clinical trials (86) 86
treatment outcome (86) 86
care and treatment (84) 84
neurology (82) 82
reperfusion (79) 79
inflammation (78) 78
cerebral blood flow (77) 77
fibrinolytic agents - therapeutic use (75) 75
mice (75) 75
aged, 80 and over (72) 72
adult (71) 71
tissue plasminogen activator - administration & dosage (71) 71
cell biology (70) 70
research (70) 70
plasmin (69) 69
rodents (69) 69
health aspects (67) 67
ischemic stroke (66) 66
medical research (66) 66
surgery (66) 66
hospitals (65) 65
gene expression (64) 64
blood (63) 63
occlusion (63) 63
u-plasminogen activator (63) 63
brain ischemia - drug therapy (61) 61
tissue plasminogen activator - metabolism (61) 61
blood coagulation (59) 59
veins & arteries (59) 59
bleeding (58) 58
thromboembolism (58) 58
blood-brain barrier (57) 57
cerebral infarction (57) 57
medical imaging (57) 57
animal models (56) 56
catheters (56) 56
physiology (56) 56
blood clots (55) 55
hematology (55) 55
medicine and health sciences (55) 55
enzymes (54) 54
neuroprotection (54) 54
heart attacks (53) 53
biology (52) 52
myocardial infarction (52) 52
retrospective studies (52) 52
cardiovascular disease (51) 51
cardiovascular system & cardiology (51) 51
abridged index medicus (50) 50
biology and life sciences (50) 50
cardiovascular diseases (50) 50
biochemistry & molecular biology (49) 49
transformation (49) 49
magnetic resonance imaging (48) 48
thrombolytic therapy - methods (48) 48
lysis (47) 47
neuroimaging (47) 47
physiological aspects (47) 47
rats (47) 47
cardiovascular system (46) 46
general & internal medicine (46) 46
thrombolytic therapy (46) 46
plasminogen (45) 45
diabetes (44) 44
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of cellular biochemistry, ISSN 0730-2312, 01/2018, Volume 119, Issue 1, pp. 17 - 27
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 08/2011, Volume 365, Issue 6, pp. 518 - 526
Journal Article
Brain (London, England : 1878), ISSN 0006-8950, 2012, Volume 135, Issue 11, pp. 3251 - 3264
.... Tissue plasminogen activator is a serine protease that converts plasminogen to plasmin, a protease that dissolves blood clots... 
traumatic brain injury | matrix metalloproteinase-3 | plasminogen activator inhibitor-1 | tissue plasminogen activator | neurovascular unit | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Capillary Permeability - physiology | Tissue Plasminogen Activator - metabolism | Brain Injuries - drug therapy | Humans | Middle Aged | Injections, Intraventricular | Capillary Permeability - drug effects | Male | Brain Injuries - metabolism | Brain Injuries - physiopathology | Plasminogen Activator Inhibitor 1 - physiology | Matrix Metalloproteinase Inhibitors - therapeutic use | Brain - metabolism | Dose-Response Relationship, Drug | Brain - blood supply | Tissue Plasminogen Activator - antagonists & inhibitors | Plasminogen Activator Inhibitor 1 - metabolism | Aged, 80 and over | Recovery of Function - physiology | Adult | Disease Models, Animal | Albumins - metabolism | Mice, Inbred C57BL | Plasminogen Activator Inhibitor 1 - administration & dosage | Tissue Plasminogen Activator - administration & dosage | Tissue Plasminogen Activator - physiology | Animals | Brain Injuries - cerebrospinal fluid | Aged | Mice | Matrix Metalloproteinases - metabolism | Index Medicus | Abridged Index Medicus | Stroke | Central nervous system | Membrane permeability | Albumin | Homeostasis | Cerebrospinal fluid | Matrix metalloproteinase | Permeability | Trauma | Plasmin | t-Plasminogen activator | lipoprotein receptors | neuroserpin | plasminogen | Proteolysis | Plasma membranes | Chromium | Serine proteinase | Brain injury | Original
Journal Article
Current drug targets, ISSN 1389-4501, 09/2017, Volume 18, Issue 12, pp. 1399 - 1407
...). The aim of this study was to explore the efficacy and safety of intraventricular injections of recombinant tissue plasminogen activator (rt-PA). Methods... 
Recombinant tissue plasminogen activator | Intraventricular hemorrhage | Subarachnoid hemorrhage | Aneurysm | Meta-analysis | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Sensitivity analysis | Hydrocephalus | Vasoconstriction | Clinical trials | Recovery of function | Aneurysms | Dosage | Hemorrhage | Patients | t-Plasminogen activator | Subgroups
Journal Article